Johnson & JohnsonChange company Symbol lookupSelect an option...JNJ Johnson & JohnsonIBM International Business Machines CorpSR Spire IncDCF BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.KTRA Kintara Therapeutics IncGLDI Credit Suisse X-Links Gold Shares Covered Call ETNBILL Bill.com Holdings IncAUB Atlantic Union Bankshares CorpTSM Taiwan Semiconductor Manufacturing Co LtdSTNG Scorpio Tankers IncGo
Change company Symbol lookup
Select an option...
JNJ Johnson & Johnson
IBM International Business Machines Corp
SR Spire Inc
DCF BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
KTRA Kintara Therapeutics Inc
GLDI Credit Suisse X-Links Gold Shares Covered Call ETN
BILL Bill.com Holdings Inc
AUB Atlantic Union Bankshares Corp
TSM Taiwan Semiconductor Manufacturing Co Ltd
STNG Scorpio Tankers Inc
Health Care : Pharmaceuticals | Large Cap Blend
Company profileJohnson & Johnson is a holding company that is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates through three segments: Consumer Health, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.
|
|
|
|
| |
| Latest Earnings Met Consensus (Q3 ending 09/2022) | Next Earnings Announcement | ||||
|---|---|---|---|---|---|
| Q3 Non-GAAP earnings GAAP vs. Non-GAAP EarningsTD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Announced October 18, 2022 | $2.55 | Q3 Estimate range of 14 analysts | $2.21 to $2.64 | Q4 Earnings will announce | (Unconfirmed) January 24, 2023 |
Quarterly Earnings History and Estimates
Show high-low estimates
Draw trendlines
Draw up to 3 lines inside the chart.
JNJ's fiscal year ends in December
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2022. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.